Enveric Biosciences Inc (ENVB)
0.90
+0.11
(+14.21%)
USD |
NASDAQ |
May 16, 16:00
0.892
-0.01
(-0.89%)
After-Hours: 06:29
Enveric Biosciences Cash from Financing (Quarterly): -0.1861M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1861M |
| September 30, 2023 | -0.105M |
| June 30, 2023 | -1.052M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.00 |
| September 30, 2022 | 7.824M |
| June 30, 2022 | 0.958M |
| March 31, 2022 | 9.398M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.00 |
| June 30, 2021 | 0.0179M |
| March 31, 2021 | 24.88M |
| December 31, 2020 | 3.599M |
| September 30, 2020 | 0.2275M |
| June 30, 2020 | -1.468M |
| March 31, 2020 | 3.172M |
| December 31, 2019 | -0.1341M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.4838M |
| March 31, 2019 | 1.448M |
| December 31, 2018 | 0.2926M |
| September 30, 2018 | 5.006M |
| June 30, 2018 | -1.015M |
| March 31, 2018 | -1.590M |
| December 31, 2017 | 5.086M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0984M |
| June 30, 2017 | 0.0889M |
| March 31, 2017 | 1.337M |
| December 31, 2016 | -0.67M |
| September 30, 2016 | 4.296M |
| June 30, 2016 | 4.93M |
| March 31, 2016 | 0.2415M |
| September 30, 2015 | 0.25M |
| June 30, 2015 | 5.160M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.002M |
| March 31, 2014 | 0.05M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.0035M |
| June 30, 2013 | 0.005M |
| March 31, 2013 | 0.012M |
| December 31, 2012 | 0.003M |
| September 30, 2012 | 0.005M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.0029M |
| September 30, 2011 | 0.02M |
| June 30, 2011 | 0.0066M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.468M
Minimum
Jun 2020
24.88M
Maximum
Mar 2021
2.506M
Average
--
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 2.323M |
| Societal CDMO Inc (DELISTED) | -0.854M |
| Cardiff Oncology Inc | 0.107M |
| BioVie Inc | 4.922M |
| Adial Pharmaceuticals Inc | 3.384M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.751M |
| Free Cash Flow | -14.10M |
| Free Cash Flow Per Share (Quarterly) | -0.7664 |
| Free Cash Flow Yield | -725.7% |